Bangalore-based Strides Arcolab has sold 94 per cent shareholding in Ascent Pharmahealth, its subsidiary with operations in Australia and Southeast Asia, to NYSE-listed Watson Pharmaceuticals for AU$ 375 million (Rs
Drug maker Strides Arcolab today said it is in talks with Ascent Pharmahealth, listed on the Australian Stock Exchange, for acquiring a minority stake in the company.
Stay informed on our latest news!